Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Vertex Pharmaceuticals Incorporated    VRTX

Delayed Quote. Delayed  - 12/02 10:14:59 pm
75.5 USD   -2.98%
12/02 VERTEX PHARMACE : VRTX) Files An 8-K Departure of Directors or Certa..
11/29 NASDAQ 100 MOVE : Bmrn, nflx
11/11 NASDAQ 100 MOVE : Alxn, nvda
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
Latest news on VERTEX PHARMACEUTICALS INC
12/02 VERTEX PHARMACEUTICALS INCORPORATED : VRTX) Files An 8-K Departure of Directors..
12/02 VERTEX PHARMACEUTICALS INC / MA : Change in Directors or Principal Officers (for..
11/29 NASDAQ 100 MOVERS : Bmrn, nflx
11/17 VERTEX PHARMACEUTICALS INCORPORATED : Positive Phase 3 Study of ORKAMBI® in Chil..
11/14 VERTEX PHARMACEUTICALS INCORPORATED : Assigned Patent
11/11 NASDAQ 100 MOVERS : Alxn, nvda
11/10 VERTEX PHARMACEUTICALS INCORPORATED : to Present at the Credit Suisse Healthcare..
11/09 VERTEX PHARMACEUTICALS INCORPORATED : (VRTX) Pops 11.92% for November 09
11/07 VERTEX PHARMACEUTICALS INCORPORATED : Positive Phase 3 Study of ORKAMBI® in Chil..
11/03 VERTEX PHARMACEUTICALS INCORPORATED : Announces Planned Initiation of Phase 2 St..
11/03 VERTEX PHARMACEUTICALS INCORPORATED : Presents Long-Term Data Demonstrating that..
11/02 VERTEX PHARMACEUTICALS INCORPORATED : to Present at the Credit Suisse Healthcare..
10/31 VERTEX PHARMACEUTICALS INCORPORATED : INC / MA Management's Discussion and Analy..
10/27 VERTEX PHARMACEUTICALS INCORPORATED : Presents Long-Term Data Demonstrating that..
10/26 VERTEX PHARMACEUTICALS INCORPORATED : Falls 2.51% for October 24
10/25 VERTEX PHARMACEUTICALS INC / MA : Results of Operations and Financial Condition,..
10/25 VERTEX PHARMACEUTICALS INCORPORATED : Pharma reports 3Q loss
10/25 VERTEX PHARMACEUTICALS INCORPORATED : Reports Third Quarter 2016 Financial Resul..
10/25 VERTEX PHARMACEUTICALS INCORPORATED : Announces Planned Initiation of Phase 2 St..
10/24 NASDAQ 100 MOVERS : Vrtx, tmus
10/24 S&P 500 MOVERS : Col, qrvo
10/20 VERTEX PHARMACEUTICALS INCORPORATED : to Announce Third Quarter 2016 Financial R..
10/18 VERTEX PHARMACEUTICALS INCORPORATED : VRTX) Files An 8-K
10/17 VERTEX PHARMACEUTICALS INC / MA : Entry into a Material Definitive Agreement (fo..
10/14 VERTEX PHARMACEUTICALS INC / MA : Entry into a Material Definitive Agreement, Ot..
10/07 VERTEX PHARMACEUTICALS INCORPORATED : to Announce Third Quarter 2016 Financial R..
09/29 VERTEX PHARMACEUTICALS INCORPORATED : VRTX): Get In While Markets Look The Othe..
09/28 VERTEX PHARMACEUTICALS INCORPORATED : U.S. Food and Drug Administration Approves..
09/22 NASDAQ 100 MOVERS : Bmrn, bbby
09/20 New Crystallization Development Methods Revealed in On-Demand Webinars from M..
09/19 New Crystallization Development Methods Revealed in On-Demand Webinars from M..
09/16 NASDAQ 100 MOVERS : Expe, wdc
09/15 VERTEX PHARMACEUTICALS INCORPORATED : Investigators at Vertex Pharmaceuticals In..
09/15 VERTEX PHARMACEUTICALS INCORPORATED : Researchers from Vertex Pharmaceuticals In..
09/15 VERTEX PHARMACEUTICALS INCORPORATED : to Present at Upcoming Investor Conference..
09/15 VERTEX PHARMACEUTICALS INCORPORATED : Patent Issued for Solid Forms of 3-(6-(1-(..
09/09 VERTEX PHARMACEUTICALS INCORPORATED : to Present at Upcoming Investor Conference..
08/29 NASDAQ 100 MOVERS : Gild, tmus
08/22 S&P 500 MOVERS : Mro, regn
08/15 VERTEX PHARMACEUTICALS INCORPORATED : Provides Update on Ongoing Phase 3 Program..
08/11 OPHTHOTECH : Announces Election of Ian F. Smith, Vertex Executive Vice President..
08/04 VERTEX PHARMACEUTICALS : Trek Therapeutics Acquires Two Antiviral Inhibitors Fro..
08/01 VERTEX PHARMACEUTICALS : MA Management's Discussion and Analysis of Financial Co..
07/28 VERTEX PHARMACEUTICALS : Researchers Submit Patent Application, "Processes for P..
07/28DJU.S. HOT STOCKS : Hot Stocks to Watch
07/27DJVERTEX PHARMACEUTICALS : Pharma Loss Narrows as Cystic Fibrosis Drug Sales Grow
07/27 VERTEX PHARMACEUTICALS INC / MA : Results of Operations and Financial Condition,..
07/27 VERTEX PHARMACEUTICALS : reports 2Q loss
07/27 VERTEX PHARMACEUTICALS : Reports Second Quarter 2016 Financial Results
07/22 VERTEX PHARMACEUTICALS : Moderna discuss mRNA Therapeutics in cystic fibrosis
07/21 VERTEX PHARMACEUTICALS : to Announce Second Quarter 2016 Financial Results on Ju..
07/14 VERTEX PHARMACEUTICALS : Researchers at Vertex Pharmaceuticals Target Influenza ..
07/14 VERTEX PHARMACEUTICALS : to Announce Second Quarter 2016 Financial Results on Ju..
07/06 VERTEX PHARMACEUTICALS : and Moderna to develop cystic fibrosis mRNA Therapeutic..
07/06 VERTEX PHARMACEUTICALS : and Moderna Establish Exclusive Collaboration to Discov..
07/01 VERTEX PHARMACEUTICALS : Exploring the need for mutation-specific treatments in ..
06/23 VERTEX PHARMACEUTICALS : Reports from Vertex Pharmaceuticals Describe Recent Adv..
06/18 VERTEX PHARMACEUTICALS INCORPORATED : (VRTX) Stock Rating Reaffirmed by Jefferie..
06/17 VERTEX PHARMACEUTICALS : Orkambi’s cost too high for benefit offered, says..
06/16 VERTEX PHARMACEUTICALS : New Findings from Vertex Pharmaceuticals Inc. in the Ar..
06/15 VERTEX PHARMACEUTICALS INC / MA : Change in Directors or Principal Officers (for..
06/10 VERTEX PHARMACEUTICALS : Announces Presentations of Data for KALYDECO® (ivacafto..
06/09 VERTEX PHARMACEUTICALS : U.S. FDA Accepts for Priority Review Supplemental New D..
06/09 VERTEX PHARMACEUTICALS : to Present at the Goldman Sachs Healthcare Conference o..
06/02 VERTEX PHARMACEUTICALS : Spero Therapeutics Acquires Novel Gyrase Inhibitors fro..
06/02 VERTEX PHARMACEUTICALS : Study Results from Vertex Pharmaceuticals Provide New I..
05/31 VERTEX PHARMACEUTICALS : to Present at the Goldman Sachs Healthcare Conference o..
05/31 VERTEX PHARMACEUTICALS : U.S. FDA Accepts for Priority Review Supplemental New D..
04/28 VERTEX PHARMACEUTICALS : Patent Issued for Solid Forms of 3-(6-(1-(2,2-Difluorob..
04/28 VERTEX PHARMACEUTICALS : to Announce First Quarter 2016 Financial Results on Apr..
04/27 VERTEX PHARMACEUTICALS : reports 1Q loss
04/27 VERTEX PHARMACEUTICALS : Reports First Quarter 2016 Financial Results
04/21 VERTEX PHARMACEUTICALS : New Fenamates Study Findings Have Been Reported from Ve..
04/19 VERTEX PHARMACEUTICALS : Enterome signs IBD therapy agreement with Vertex
04/18 S&P 500 MOVERS : Chk, has
1  2  3  4  5  6  7Next
Advertisement
Financials ($)
Sales 2016 1 693 M
EBIT 2016 182 M
Net income 2016 -134 M
Finance 2016 185 M
Yield 2016 -
P/E ratio 2016 -
P/E ratio 2017 74,98
EV / Sales 2016 10,9x
EV / Sales 2017 8,32x
Capitalization 18 727 M
More Financials
Chart VERTEX PHARMACEUTICALS INC
Duration : Period :
Vertex Pharmaceuticals Inc Technical Analysis Chart | VRTX | US92532F1003 | 4-Traders
Full-screen chart
Technical analysis trends VERTEX PHARMACEUT...
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus 
Mean consensus OUTPERFORM
Number of Analysts 24
Average target price 102 $
Spread / Average Target 35%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Jeffrey M. Leiden Chairman, President & Chief Executive Officer
Simon Bedson SVP & GM-International Commercial Operations
Ian F. Smith Chief Financial Officer & Executive Vice President
Jeffrey A. Chodakewitz Chief Medical Officer & Executive Vice President
David Matthew Altshuler Chief Scientific Officer & EVP-Global Research
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
VERTEX PHARMACEUTICALS..-35.14%18 727
AMGEN, INC.-11.25%107 132
GILEAD SCIENCES, INC.-27.17%95 410
CELGENE CORPORATION-1.78%91 187
REGENERON PHARMACEUTIC..-31.34%39 310
ACTELION LTD40.40%21 739
More Results